Search results for the GEO ID: GSE7292
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM174821
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 1 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 untreated immunomagnetically selected primary CD19+ B-cells
GSM174822
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 2 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 1 untreated immunomagnetically selected primary CD19+ B-cells
GSM174823
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 3 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of a healthy donor untreated immunomagnetically selected primary CD19+ B-cells
GSM174824
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 4 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 untreated immunomagnetically selected primary CD19+ B-cells
GSM174825
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 5 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of a healthy donor untreated immunomagnetically selected primary CD19+ B-cells
GSM174826
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 6 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 untreated immunomagnetically selected primary CD19+ B-cells
GSM174827
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 7 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 4 untreated immunomagnetically selected primary CD19+ B-cells
GSM174828
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab control 8 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 2 untreated immunomagnetically selected primary CD19+ B-cells
GSM174867
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 1 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174875
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 2 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174876
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 3 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 2 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174877
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 4 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 2 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174878
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 5 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 2 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174879
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 6 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 1 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174880
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 100 µCi, 46 min, sample 7 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 4 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174881
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 1 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174882
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 2 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 3 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174892
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 3 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 4 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174893
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 4 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 4 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
GSM174894
GPL201
Alpha-irradiated primary CD19+ B-cells with the radioimmuno-conjugate Bi-213-CD20-Rituximab 200 µCi, 46 min, sample 5 Primary CD19+ B-Cells Immunomagnetically selected from peripheral blood of healthy donor 1 Bi-213-CD20-Rituximab irradiated primary CD19+ B-cells
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes